BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
2.320
+0.070 (3.11%)
Apr 26, 2024, 10:50 AM EDT - Market open

BioAtla Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021202020192018
Market Capitalization
1121183107231,054--
Market Cap Growth
--61.99%-57.09%-31.39%---
Enterprise Value
-1999483816144
PE Ratio
-0.95-0.95-2.91-7.58-29.40--
PS Ratio
---2892.352456.70--
PB Ratio
1.531.671.723.435.02--
P/FCF Ratio
-1.13-1.13-3.42-11.45-28.54--
P/OCF Ratio
-1.13-1.13-3.43-11.62-29.01--
EV/Sales Ratio
---1933.921902.102.770.39
EV/EBITDA Ratio
-0.07-0.07-0.94-5.14-24.39-0.53-0.15
EV/EBIT Ratio
-0.07-0.07-0.93-5.07-23.68-0.51-0.15
EV/FCF Ratio
-0.09-0.09-1.09-7.66-22.10-1.29-0.11
Debt / Equity Ratio
0.030.030.020.030.00-0.32-0.53
Debt / EBITDA Ratio
-0.02-0.02-0.04-0.06-0.02-0.66-0.55
Debt / FCF Ratio
-0.02-0.02-0.04-0.09-0.02-1.62-0.41
Quick Ratio
3.933.939.3212.367.400.141.18
Current Ratio
4.114.119.5312.487.460.171.38
Asset Turnover
0000.000.000.40-
Interest Coverage
----31799.67-24.81-17.28-29.54
Return on Equity (ROE)
-110.60%-110.60%-62.80%-46.80%-46.60%70.60%-
Return on Assets (ROA)
-75.40%-75.40%-49.60%-39.00%-28.20%-229.40%-
Return on Capital (ROIC)
-177.33%-177.33%-58.67%-44.61%-14.29%74.70%209.68%
Earnings Yield
-114.09%-104.70%-34.32%-13.19%-3.40%--
FCF Yield
-96.21%-88.29%-29.23%-8.73%-3.50%--
Buyback Yield / Dilution
-22.74%-22.74%-12.63%-310.07%84.56%--
Total Shareholder Return
-22.74%-22.74%-12.63%-310.07%84.56%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).